NOX 1.52% 6.7¢ noxopharm limited

Ann: Pre-clinical Data Supports a Role for Veyonda in COVID-19, page-6

  1. 580 Posts.
    lightbulb Created with Sketch. 355
    Yeah something really has got the old boy riled up. I guess we do owe the old Novogen shareholders thanks for funding so much of the foundational research. And maybe we don't say thank you enough.

    But I'm a littled worried about him operating a chainsaw in this mental state. Veyonda can't regrow limbs (yet).
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.